U.S. market Closed. Opens in 18 hours 43 minutes

CDIO | Cardio Diagnostics Holdings, Inc. Stock Overview

(Stock Exchange: NASDAQ)
Day's Range 1.5200 - 2.0500
52 Week Range 0.1710 - 8.50
Beta N/A
Implied Volatility N/A
IV Rank N/A
Day's Volume 3,462,919
Average Volume 13,718,658
Shares Outstanding 20,516,900
Market Cap 31,801,195
Sector Healthcare
Industry Biotechnology
IPO Date 2022-01-14
P/E Ratio -2.18
Forward P/E Ratio N/A
EPS -0.71
1YR Price Target N/A
Dividend Yield N/A
Dividend Per Share N/A
Dividend ExDate N/A
Dividend PayDate N/A
Employees 7
Country USA
Website CDIO
Cardio Diagnostics Holdings, Inc. develops and commercializes epigenetics-based clinical tests for cardiovascular disease. It offers Epi+Gen CHD, a three-year symptomatic coronary heart disease risk assessment test. Cardio Diagnostics Holdings, Inc. was founded in 2017 and is based in Chicago, Illinois.
*Chart delayed
Analyzing fundamentals for CDIO we got that it has weak fundamentals where Valuation is considered to be significantly overvalued, Profitability is unacceptably poor, Growth is desperately bad and Health is very weak. For more detailed analysis please see CDIO Fundamentals page.

Watching at CDIO technicals we can see that long-term trend is bearish, while middle-term trend is bullish, as well as bullish short-term trend. More technicals details can be found on CDIO Technicals page.
An error has occurred. This application may no longer respond until reloaded. Reload 🗙